Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Juan Felix MD
Vice Chair, Director, Professor
Department of Pathology
Division of Administration

OFFICE ADDRESS:
Froedtert/MCW Laboratory Building
9200 W Wisconsin Ave
Milwaukee, WI 53226
Email: jcfelix@mcw.edu

EDUCATION:
1972 - 1976 High School, Schreiber High School, Port Washington, NY
1976 - 1980 College, Columbia College, Columbia University B.A., New York, NY
1980 - 1984 Medical School, Cornell University Medical College, MD, New York, NY

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1985 - 1988 Residency, Anatomic Pathology, The New York Hospital, New York, NY
1988 - 1989 Fellowship, Obstetrical & Gynecological Pathology, The New York Hospital - Cornell University Medical College, New York, NY

FACULTY APPOINTMENTS:
1989 - 1992 Assistant Professor, Pathology, Cornell University
1992 - 1995 Assistant Professor, Clinical Pathology, Obstetrics & Gynecology, Keck School of Medicine
1995 - 2001 Associate Professor, Clinical Pathology, Obstetrics & Gynecology, Keck School of Medicine
2002 - 2017 Professor, Clinical Pathology, Obstetrics & Gynecology, Keck School of Medicine
2017 - Present Professor, Pathology, Anatomic Pathology, Medical College of Wisconsin
2018 - Present Professor, Surgery, Medical College of Wisconsin

ADMINISTRATIVE APPOINTMENTS:
1994 - 2009 Director of Molecular Pathology, Women's and Children's Hospital
1994 - 2009 Director of Pathology, LAC-USC Women's and Children's Hospital
1998 - 2002 Director of Resident Recruitment, Los Angeles County Women's and Children's Hospital
2007 - 2017 Director of Cytopathology Fellowship, LAC + USC
2007 - 2017 Chief of Cytopathology, LAC + USC
2010 - 2017 Director of USC Labs, Outreach Anatomic Pathology
2011 - 2013 Chief of Anatomic Pathology, Keck Medical Center of USC
2013 - 2014 Associate Director of Operations and Quality in Anatomic Pathology, LAC + USC Medical Center
2018 - Present Residency Director, Medical College of Wisconsin

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
2008 - Present Scientific Director, Basic Health International, info@basichealth.org

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
1989 - 1992 Attending Pathologist and Cytopathologist, The New York Hospital
1992 - 2009 Attending Pathologist and Cytopathologist, Los Angeles County Women's and Children's Hospital
1994 - 2017 Chief, OB-GYN Pathology, LAC + USC Medical Center
1994 - 2009 Director, Surgical Pathology, Los Angeles County Women's and Children's Hospital
2004 - 2005 Acting Chief of Anatomic Pathology, Pathology and Laboratory Medicine, LAC + USC
2007 - 2017 Chief of Cytopathology, LAC + USC Medical Center
2007 - 2017 Director of Cytopathology Fellowship
2010 - 2011 Interim AP Chief, University Hospital and Norris Cancer Center
2011 - 2013 Chief, Anatomic Pathology, Keck Medical Center of USC
2013 - 2014 Associate Director of Operations and Quality, Anatomic Pathology, LAC + USC
2017 - Present Director of Anatomic Pathology and Vice-Chair, Pathology, Medical College of Wisconsin

RESEARCH ADMINISTRATIVE APPOINTMENTS:
1988 - Present Investigation in human papillomavirus, pathogenesis and pathobiology
1991 - Present Diagnosis and treatment of preinvasive lesions of the uterine cervix
1992 - 2006 Pathobiology of endometrial adenocarcinoma and its precursors
1994 - 2006 Effect of estrogen replacement therapy on the endometrium of postmenopausal women
1998 - 2006 Biological markers of progression in Gestational Trophoblastic Disease
1999 - 2005 Role of prostaglandin EP3 receptors in myometrial contractility
2006 - Present Cervical cancer prevention in low and middle income countri

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Diplomate of the American Board of Pathology (Anatomic Pathology)
1988
None
Certified for Added Qualification in Cytopathology
1993
None
   
Licensure
Number Issue DateExpiration
New York State
168870
1986
None
California
G73369
1992
None
Arizona
42555
2009
None
Texas
N6291
2009
None
Wisconsin
67502-20
2017
None
New Jersey
25MA07738100
2019
None
    

AWARDS AND HONORS:
1984 Member, Puerto Rico Olympic Team, Single Sculls, Los Angeles, CA
1988 Member, Puerto Rico Olympic Team, Single Sculls, Seoul, Korea
1998 - 2002 Advisory Committee Service Award , U.S. Food and Drug Administration

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1982 - Present National Association for the Advancement of Science (Member)
1984 - Present New York State Medical Society (Member)
1992 - Present American Society of Clinical Pathology (Member)
1992 - Present Gynecologic Oncology Group (Member)
1992 - Present American Society of Investigational Pathology (Member)
1997 - Present FDA Hematology and Pathology Devices Committee (Member)
1998 - Present American Society of Colposcopy and Cervical Pathology Clinical Practice Guidelines (Member)
2017 - Present Radiological Society of North America (Member)

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1992 - 2008 Member, Women’s Hospital Quality Assurance Committee, LAC + USC Medical Center
1992 - 1994 Member, Education Policy Committee Representative for the Department of Pathology, Keck School of Medicine USC
1993 - 2017 Member, Credentials and Peer Review Committee, Department of Pathology, LAC + USC Medical Center
1999 - 2005 Member, Curriculum Revision Committee, Keck School of Medicine USC
2000 - 2017 Co-Chair, Reproduction Systems Committee
2010 - 2017 Member, USC Department of Pathology Promotions Committee
2019 - Present Member, Medical College Physicians (MCP) Patient Services and Operations Committee, Medical College of Wisconsin
2019 - Present Member, Precision Medicine Oversight Committee, Medical College of Wisconson
2019 - Present Member, Medical College of Wisconsin Affiliated Hospitals (MCWAH) Graduate Medical Education Committee, Medical College of Wisconsin
2019 - Present Member, Peer Review Committee, Medical College of Wisconsin

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1993 Speaker Workshop on Loop Electrosurgical Excision Procedures, County-Harbor UCLA Medical Center
2000 - 2005 scientific consultant, Cervical cancer screening at McLaughlin Indian Health Center for the Native American Pap Initiative
2002 - 2008 Medical Director, Pathnet Laboratory, Van Nuys, CA
2010 - 2012 Regional Medical Director, Laboratory Corporation of America

INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2008 - Present Scientific Director, Basic Health International

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Cryopen: An innovative treatment for cervical precancer
Source:
NIH/UH2-UH3 award 614-SUB
Role:
Co-Investigator
Dates:
2014 - 2021
  
Title:
Development of an LMIC-adapted Thermocoagulation Prototype for Treatment of Cervical Pre-cancer
Source:
NIH/RO1 CA 218195
Role:
Co-Investigator
Dates:
2019 - 2022
  
Title:
Low-cost (AmpFire) HPV Testing
Source:
NIH
Role:
Co-Investigator
Dates:
2019 - 2021
  
Prior
Peer Review
Title:
Human Papilloma Virus in lesions of the lower genitourinary tract
Source:
Winston Foundation Grant Award
PI:
Principal Investigator
Dates:
1988 - 1990
Direct Funds:
$150,000
  
Title:
The effect of phenytoin on human papilloma virus associated lesions
Source:
The Health Foundation Research Award
PI:
Principal Investigator
Dates:
1988 - 1990
Direct Funds:
$120,000
  
Title:
A Case Control Study of Ovarian Cancer in the County of Los Angeles
Source:
National Cancer Institute, RO1 CA61132-01
Role:
Pathology reviewing histopathology, Collaborator
Dates:
1993 - 1998
Direct Funds:
$1,500,610
  
Title:
Role of EP3 Isoforms in Myometrial Contractility
Source:
NIH/RO1 HD 40917-01
Role:
Co-Investigator
Dates:
2003 - 2006
  
Title:
Nonoxynol-9 effect on human endometrium in vivo and in vitro
Source:
NIH/ RO3 HDO 47322
Role:
Co-Investigator
Dates:
2004 - 2007
  
Title:
Prospective, randomized, placebo-controlled study of mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate
Source:
NIH/ RO-1 HD 43189
Role:
Co-Investigator
Dates:
2005 - 2008
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Regional
Invited speaker on Adenocarcinoma of the uterine cervix -Ground Rounds, University of Southern California, Department of Pathology, 1993
Invited speaker on Endometrial proliferation in post-menopausal women on hormone replacement therapy - Grand Rounds, University of Southern California, Department of OB/GYN, 1995
Invited speaker on cervical adenocarcinoma diagnosis and treatment, University of California, Department of OB/GYN, 1997
Invited speaker on the Role of HPV in the diagnosis and triage of patients with abnormal Pap smears - Grand Rounds, University of California Los Angeles, Department of Pathology, 1998
Invited speaker on Adenocarcinoma of the uterine cervix - Grand Rounds, Stanford University, Department of OB/GYN, 1998
Invited speaker at the University of California Irvine - Grand Rounds, University of California Irvine, Department of OB/GYN, 1999
Invited speaker at the California Campus of California Pacific Medical Center - Grand Rounds, California Pacific Medical Center, Department of OB/GYN, 1999
Invited panelist at the FDA Hematology and Pathology Devices Meeting, Rockville, MD, 1999
Invited speaker at the University of Texas-Houston Health Science Center - Grand Rounds, University of Texas-Houston, Department of OB/GYN, 1999
Invited panelist at the FDA Microbiology Devices Meeting, Gaithersburg, MD, 2000
Invited speaker Cancer in Women: A Comprehensive Scientific Symposium on the Gynecologic Malignancies (NOCC) on Pre-invasive and Invasive Cancer of the Cervix, San Diego, CA, 2000
Invited speaker on Cervical Cancer Screening for the Medical Education Speakers Network, Van Nuys, CA, 2001
Invited speaker on Improving Accuracy of Cervical Cancer Screening for OB/GYN Section Meeting, Dallas, Texas, 2001
Invited speaker on Colposcopic Precursors for the Medical Education Speakers Network, Baldwin Park, CA, 2001
Invited speaker on Endometrial Hyperplasia – Therapeutic Option for Women Desiring Fertility for the Medical Education Speakers Network, St Joseph’s Hospital. Orange, CA, 2001
Invited speaker at the Centers for Disease Control and Prevention (CDC), Prevention Research Centers Programs (PRC) Grant Review Panel Meeting, Atlanta, Georgia, 2001
Invited participant on HPV DNA Testing: Early Identification of Women with Cervical Neoplasia for the Medical Education Speakers Network, Los Angeles, CA, 2001
Invited lecturer on Gynecologic Cytology Past, Present and Future and Future by the National Cervical Cancer Coalition, Las Vegas, Nevada, 2001
Invited speaker at the 29th Annual Institute and Conference for the National Black Nurses Association, Los Angeles, CA, 2001
Invited speaker on Cervical Cancer and Cervical Cancer Screening for the Medical Education Speakers Network, Covina, CA, 2001
Invited speaker on Cervical Cancer for the Medical Education Speakers Network, Los Angeles, CA, 2001
Invited speaker on Diagnosis, Management and Prognosis of the Endometrial Hyperplasia, Los Angeles, CA, 2001
Invited lecturer on Advances in Cervical Screening at Cytology Services Group, Brotman Medical Center, Culver City, CA, 2002
Invited speaker on Advances in Cervical Screening at the Denver Health Medical Center Campus, Department of OB-GYN Grand Rounds, Denver, Colorado, 2002
Invited speaker on ASCCP Guidelines for the Management of the Abnormal Pap Smear, Keck School of Medicine, University of Southern California Women’s and Children’s Hospital, Department of OB/GYN Grand Rounds, Los Angeles, CA, 2002
Invited speaker on Advances in Cervical Screening, Stanford University Hospital Grand Rounds, Stanford, CA, 2002
Invited lecturer on Cervical Screening in the New Millennium, St. Louis University St. Mary’s Health Care Center Department of OB-GYN Grand Rounds, St. Louis, Missouri, 2002
Invited speaker at the 6th Annual Women’s Cancer Center Great Debates, Pap Smear ThinPrep v. Cytobrush, Ruoff Resort at Squaw Creek, Lake Tahoe, 2002
Invited speaker by Watson Pharmaceutical on Controversies and Challenges in Interpreting Abnormal Pap Smear, Newport Coast, CA, 2002
Invited speaker on Update on Screening and Triage of the Abnormal Pap Smear a CME by the NOCC, Carolyn Marks Memorial Annual Scientific Symposium, Miami Beach, FL, 2002
Invited panelist at the FDA Microbiology Panel Meeting, Gaithersburg, MD, 2002
Invited speaker on The New Bethesda Management of Abnormal Pap Smears, Cytology Association of San Antonio, San Antonio, Texas, 2002
Invited speaker on Management of the Abnormal Pap ASCUS/AGUS, West Hills Hospital, West Hills, CA, 2002
Invited speaker on Abnormal Pap, Community Hospital Network at Suburban Medical Center in Paramount, CA, 2002
Invited speaker at Medispectra Pivotal Investigators Meeting, Waltham, MA, 2002
Invited speaker at the ACOG 50th Annual Clinical Meeting, The Science Behind the Effectiveness of In-Vivo Screening a CME symposium Shedding a New Light on Bethesda III: New Technologies in Cervical Screening, Los Angeles, CA, 2002
Invited speaker on Update on Pap Smear Testing for the Medical Education Speakers Network, Sun Valley, CA, 2002
Invited speaker on Management of AGUS for the Medical Education Speakers Network, Baldwin Park, CA, 2002
Invited speaker on Management of Cervical Cancer Precursor Lesions for the Medical Education Speakers Network, Lancaster, CA, 2002
Invited speaker on Bethesda 2002 and ASCCP at the 32nd Annual Meeting Texas Society of Cytology, San Antonio, Texas, 2002
Invited speaker on Management of Abnormal Pap at Harbor-UCLA for the Women’s Health Care Nurse Practitioner Program, Torrance, CA, 2002
Invited speaker on Bethesda Guidelines at the Iowa’s Annual Family Planning Conference, Des Moines, Iowa, Iowa, 2002
Invited speaker on Updates to the Bethesda System: 2002, OB/GYN The Cutting Edge, Universal City, 2002
Invited speaker on Management of Abnormal Pap Smears for the Women’s Health Care Practice Update and Certification Course, San Pedro, CA, 2002
Invited speaker on Diagnosis and Prognosis of Endometrial Hyperplasia, Los Angeles County University of Southern California Medical Center and the Keck School of Medicine of the University of Southern California, Department of Pathology and Laboratory Medicine Grand Rounds, Los Angeles, CA, 2002
Invited speaker on a Summary of LA County Mobile Pap Services and establishment of regional working groups, LA County Department of Health Services Cervical Cancer Planning Council Conference Santa Barbara, CA, 2002
Invited speaker on HPV and Cervical Neoplasia, California Family Health Council Women’s Health Update Burlingame, San Francisco, CA, 2002
Invited speaker on Update on Screening and Triage of the Abnormal Pap Smear at the Women’s Cancer SGO’s 34th Annual Meeting, New Orleans, Louisiana, 2003
Invited speaker on Emerging Concepts in Uterine Contractility During Labor, Neonatology Fellowship Program, University of Southern California Los Angeles, CA, 2003
Invited speaker on Pathology and Neoplasia, Keck School of Medicine, University of Southern California Women’s and Children’s Hospital, Los Angeles, CA, 2003
Invited speaker on Update on Pap smears a CME Program, Medical Education Speakers Network at St. Jude Medical Center, Fullerton, CA, 2003
Invited speaker on Management of Endometrial Hyperplasia, Keck School of Medicine, University of Southern California Women’s and Children’s Hospital, Department of OB/GYN Grand Rounds, Los Angeles, CA, 2003
Invited speaker on Bethesda III, Planned Parenthood, Des Moines, Iowa, 2003
Invited speaker on Pap Smears and HPV at the Common Problems in Primary Care - 2003. 29th Annual Review Course, USC Department of Family Medicine Keck School of Medicine and the Los Angeles County Chapter California Academy of Family Physicians Los Angeles, CA, 2003
Invited speaker on HPV Clinical Update, 2003 Solvay Pharmaceuticals, Inc Preceptorship, Women’s Health Harbor UCLA, Torrance, CA, 2003
Invited speaker, Management of endometrial cancer precursor lesions, Pacific Coast Obstetrical and Gynecological Society, 2007
Invited speaker, Management of abnormal Pap, Annual Meeting, Pacific Coast Obstetrical and Gynecological Society, 2009
Invited speaker, Human papillomavirus, past, present and future, Annual Meeting, Pacific Coast Obstetrical and Gynecological Society, 2011
Invited speaker via Teleconference on Cytology Management Guidelines, Bethesda III for The University of Texas Health Science Center San Antonio, Texas, 2013
Invited speaker, Post-surgical endometriosis, a preventable condition, Annual Meeting, Pacific Coast Obstetrical and Gynecological Society, 2013
Cervical Cancer: Genesis and Revelations, 27th Annual Val Davajan Lecture, USC Keck School of Medicine Department of OBGYN, Los Angeles, CA, 2020
Pathology of the Placenta and Significance in Medical Legal Liability, Annual Meeting of Phoenix OBGYN Group, Phoenix, AZ, 2020
 
National
Course Director, Cervical Cancer Therapy in low and middle income countries, International Papillomavirus Convention, Seattle, WA, 2014
Invited speaker, HPV Surveillance, Sunshine Seminar 2016, Rio Mar, Puerto Rico, 2016
Endometrial Hyperplasia: Diagnosis and Prognosis, 10th Annual Midwestern Conference, Milwaukee, WI, 09/16/2017
Placental Pathology: The Essentials for the Surgical Pathologist, 10th Annual Midwestern Conference, Milwaukee, WI, 09/16/2017
Invited speaker, Natural History of HPV and Cervical Screening 2017, Caribe-GYN Convention, Ponce, Puerto Rico, 2017
Adenocarcinoma of the Cervic Diagnosis and Diagnostic pitfalls, 11th Annual Midwestern Conference, 09/16/2018
Invited speaker, Update in Treatment and Antibiotics Use for Sexually Transmitted Diseases, Sunshine Seminar, San Juan, Puerto Rico, 2018
Moderator, Fireside Chat: Woman-Specific issues, 12th Annual Midwestern Conference, Milwaukee, WI, 10/05/2019
The Management of the Abnormal Pap, Part I, 12th Annual Midwestern Conference, Milwaukee, WI, 10/05/2019
The Management of the Abnormal Pap, Part II, 12th Annual Midwestern Conference, Milwaukee, WI, 10/05/2019
 
International
Invited lecturer on Human Papillomavirus in the female genital tract, Universidad de Bilbao, Colegio de Medicina de Barcelona, and Universidad de Madrid, 1990
Invited speaker at the Taiwan Association of Obstetrics and Gynecology: Cervical Screening, Taipei, Taiwan, 2001
Invited speaker at the Veteran’s General Hospital, Department of Obstetrics and Gynecology: Current Investigation and Application of Immunomicroscopic Study in Gynecologic Cancers, Taipei, Taiwan, 2001
Invited speaker at the Investigators Meeting for Endometrial Study, Istanbul, Turkey, 2001
Invited speaker at the IV Encuentro Nacional De Medicos Colposcopistas III Curso Internacional de Colposcopia, Ixtapa- Zihuatanejo, Gerrero, Mexico, 2002
Invited speaker, Cervical cancer precursor lesions: diagnosis and treatment, Sociedad de colposcopia Mexicana, Monterrey, Mexico, 2008
Course Director, Cervical cancer prevention in Central America, Congreso Internacional del Cancer Cervical, 2012, San Salvador, El Salvador, 2012
Course Director, Cervical cancer prevention in Central America, Congreso Internacional del Cancer Cervical, 2013, Panama City, Panama, 2013
Invited speaker, Salvadoran Cervical Cancer Prevention Committee, The value of Primary HPV screening in cervical cancer prevention, San Salvador, El Salvador, 2014
Invited speaker, Establishing a cervical cancer prevention program in rural El Salvador, Central American Association of Obstetrics and Gynecology, San Salvador, El Salvador, 2015
Invited speaker, Technologies in HPV detection and Management of recurrent/persistent CIN, Honduran Colposcopy Society, Tegucigalpa, Honduras, 2016
Invited speaker, Treatment Modalities for Cervical Cancer Precursor Lesions, Instituto Salvadoreno Del Seguro Social, El Salvador, 2016
Invited speaker, Placenta, V Congresso Nacional De Citologia, Quito, Ecuador, 2018
Invited speaker, HPV and Cervical Cancer, V Congresso Nacional De Citologia, Quito, Ecuador, 2018
Reproducibility in the Diagnosis of Cervical Intraepithelial Neoplasia, Xing-Xiang, China, 2019
Diagnostic Utility of Whole Slide Scanning in the Quality Assurance of Cervical Intraepithelial Neoplasia, Shenzhen, China, 2019
Implementation of a Population Based Human Papillomavirus Detection Strategy for the Prevention of Cervical Cancer, San Salvador, El Salvador, 2019
The Accurate and Reproducible Diagnosis of Cervical Intraepithelial Neoplasia, Beijing, China, 2020
Screening and Treatment of Cervical Intraepithelial Neoplasia by Human Papillomavirus Detection, Bogota, Colombia, 2020
 

COMMUNITY SERVICE ACTIVITIES:
2000 - 2009 Director, cervical cancer screening and treatment for the homeless. Community Health Fair for the homeless. Los Angeles, CA
 

CONSULTANTSHIPS:
1990 - 1999 Consultant, IMPATH (Human Papillomavirus)
1994 - 1999 Consultant, Novo Nordisk Pharmaceuticals
1996 - 2006 Consultant, CYTYC Corporation
1997 - 1999 Consultant, Morphometrix Corporation
1998 - 2000 Consultant, Rhone Poulenc Rhorer Pharmaceuticals
1998 - 2003 Consultant, 3M Pharmaceuticals
1998 - 2000 Consultant, Rhone Poulenc Rhorer Pharmaceuticals
2000 - 2007 Consultant, LifeSpex Corporation
2000 - 2008 Consultant, Organon Pharmaceuticals
2004 - 2008 Consultant, Merck
2004 - 2013 Consultant, Hologic Corporation

EXPERT REVIEWER:
1993 - Present Contraception
1994 - Present Obstetrics & Gynecology
1994 - Present Gynecologic Oncology
1999 - Present Applied Immunohistochemistry & Molecular Morphology

PATENTS:
Goharkhay N, Wing DA, Naidu Y, Felix JC. Prostaglandin receptor isoforms in the regulation of labor (provisional U.S. patent).


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Knisely AS, Magid MS, Felix JC, Singer DB. Parathyroid gland hemorrhage in perinatally lethal osteogenesis imperfecta. J Pediatr. 1988 May;112(5):720-5.
2. Wilkes MS, Fortin AH, Felix JC, Godwin TA, Thompson WG. Value of necropsy in acquired immunodeficiency syndrome. Lancet. 1988 Jul 09;2(8602):85-8.
3. McDougall CJ, Ngoi SS, Goldman IS, Godwin T, Felix JC, DeCosse JJ, Rigas B: . Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res. 1990 Dec 15;50(24):8023-7.
4. Petito CK, Morgello S, Felix JC, Lesser ML. The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab. 1990 Nov;10(6):850-9.
5. Wilkes MS, Link RN, Jacobs TA, Fortin AH, Felix JC. Attitudes of house officers toward the autopsy. J Gen Intern Med. 1990;5(2):122-5.
6. Borda ES, Sterin- Borda LJ, Pascual JO, Gorelick G, Felix JC, von Kreuter BF, Santos- Buch CA: Trypanosoma cruzi attachment to lymphocyte muscarinic cholinergic and beta adrenergic receptors modulates intracellular signal transduction. Mol Biochem Parasitol 1991 Jul;47(1):91-100.
7. Lungu O, Sun XW, Felix J, Richart RM, Silverstein S, Wright TC Jr. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA. 1992 May 13;267(18):2493-6.
8. Lungu O, Sun XW, Felix JC, Richart RM, Silverstein S, Wright TC: Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA 1992 May 13;267(18):2493-6.
9. Paler RJ, Felix JC: Desmin, myoglobin and muscle-specific actin immunohistochemical staining in a case of embryonal rhabdomyosarcoma of the ovary. Appl Immunohistochem Molecular Morphol 1992 Sep;7(3):237-41.
10. Felix JC, Cote RJ, Kramer EE, Saigo P, Goldman GH. Carcinomas of Bartholin's gland. Histogenesis and the etiological role of human papillomavirus. Am J Pathol. 1993 Mar;142(3):925-33. PMCID: PMC1886794
11. Felix JC, von Kreuter BF, Santos-Buch CA. Mimicry of heart cell surface epitopes in primary anti-Trypanosoma cruzi Lyt 2+ T lymphocytes. Clin Immunol Immunopathol. 1993 Aug;68(2):141-6.
12. Felix JC, Wright TC. Analysis of lower genital tract lesions clinically suspicious for condylomata using in situ hybridization and the polymerase chain reaction for the detection of human papillomavirus. Arch Pathol Lab Med. 1994 Jan;118(1):39-43.
13. Duggan BD, Felix JC, Muderspach LI, Tsao JL, Shibata DK. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res. 1994 Mar 15;54(6):1604-7.
14. Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D. Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst. 1994 Aug 17;86(16):1216-21.
15. Felix JC, Muderspach LI, Duggan BD, Roman LD. The significance of positive margins in loop electrosurgical cone biopsies. Obstet Gynecol. 1994 Dec;84(6):996-1000.
16. Kobak WH, Roman LD, Felix JC, Muderspach LI, Schlaerth JB, Morrow CP. The role of endocervical curettage at cervical conization for high-grade dysplasia. Obstet Gynecol. 1995 Feb;85(2):197-201.
17. Sun XW, Koulos JP, Felix JC, Ferenczy A, Richart RM, Park TW, Wright TO Jr. Human papillomavirus testing in primary cervical screening. Lancet. 1995 Sep 02;346(8975):636.
18. Park TW, Felix JC, Wright TC Jr. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res. 1995 Nov 01;55(21):4793-6.
19. Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival. Cancer Res. 1995 Dec 01;55(23):5693-8.
20. Martin-Hirsel A, Moratorio W, Felix JC. Possible acquired resistance to cervical dysplasia Cervix and the Lower Female Genital Tract. 1995;13(2):47-50.
21. Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela BH, Godorov G, Dubeau L. Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst. 1996 Apr 17;88(8):510-8.
22. Wan M, Sangiorgi F, Felix JC, Debeau L. Association of BRCA1 expression with gonadotropin-responsive cells. Lancet. 1996 Jul 20;348(9021):192-3.
23. Lukas J, Niu N, Saffarinazari B, Felix J, Jones L, Hall FL, Press MF. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary and endometrium Journal of Investigative Medicine. 1996;44(1).
24. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br J Cancer. 1997;75(3):396-402. PMCID: PMC2063379
25. DeCherney AH, Dougherty WR, Felix JC, Rodgers KE, Girgis W, Abiko M, diZerega GS. Expression of cyclin protein after thermal skin injury in a guinea pig model. J Burn Care Rehabil. 1997;18(4):292-8.
26. Felix JC, Farahmand S: Endometrial glandular proliferation and estrogen receptor content during the normal menstrual cycle. Contraception 1997 Jan;55(1):19-22.
27. Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL, Press MF. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol. 1997 Jan;150(1):167-75. PMCID: PMC1858522
28. Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L. Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst. 1997 Mar 19;89(6):437-41.
29. Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM. Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst. 1997 Aug 06;89(15):1110-6.
30. Muderspach LI, Curtin JP, Roman LD, Gebhardt JA, Klement V, Qian D, Morrow CP, Felix JC, Formenti SC, Muggia FM. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol. 1997 May;65(2):336-42.
31. Rodgers KE, DeCherney AH, St Amand KM, Dougherty WR, Felix JC, Girgis WW, diZerega GS. Histologic alterations in dermal repair after thermal injury effects of topical angiotensin II. J Burn Care Rehabil. 1997;18(5):381-8.
32. Florentine BD, Sanchez B, Raza A, Frankel K, Martin SE, Kovacs B, Felix JC. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides. Cancer. 1997 Oct 25;81(5):299-308.
33. Roman LD, Felix JC, Muderspach LI, Agahjanian A, Qian D, Morrow CP. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. Obstet Gynecol. 1997 Nov;90(5):759-64.
34. Luo MP, Gomperts B, Imren S, DeClerck YA, Ito M, Velicescu M, Felix JC, Dubeau L. Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases. Gynecol Oncol. 1997 Dec;67(3):277-84.
35. Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung CJ, Zhang Z, Ying SY, Schneyer AL, Lauchlan SC, Felix JC. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol Oncol. 1998 Apr;69(1):23-31.
36. Roman LD, Felix JC, Muderspach LI, Varkey T, Burnett AF, Qian D, Morrow CP. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 1998 Mar;68(3):220-5.
37. Moyer DL, Felix JC. The effects of progesterone and progestins on endometrial proliferation. Contraception. 1998 Jun;57(6):399-403.
38. Zheng W, Khurana R, Farahmand S, Wang Y, Zhang ZF, Felix JC. p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. Am J Surg Pathol. 1998 Dec;22(12):1463-73.
39. Karimi A, Felix JC, Kovacs BW. Prenatal determination of fetal RhD type by DNA amplification from transcervical swabs Prenatal and Neonatal Medicine. 1999;4(6):448-452.
40. Paler RJ, Felix JC. Desmin, myoglobin, and muscle-specific actin immunohistochemical staining in a case of embryonal rhabdomyosarcoma of the ovary Applied Immunohistochemistry. 1999;7(3):237-241.
41. McCluskey LL, Chen C, Delgadillo E, Felix JC, Muderspach LI, Dubeau L. Differences in p16 gene methylation and expression in benign and malignant ovarian tumors. Gynecol Oncol. 1999 Jan;72(1):87-92.
42. Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF. p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol. 1999 Jan;18(1):29-41.
43. Duggan BD, Felix JC, Muderspach LI, Gebhardt JA, Groshen S, Morrow CP, Roman LD. Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study. Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):276-82.
44. Amezcua CA, Zheng W, Muderspach LI, Felix JC. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia. Gynecol Oncol. 1999 Apr;73(1):126-36.
45. Holschneider CH, Felix JC, Satmary W, Johnson MT, Sandweiss LM, Montz FJ. A single-visit cervical carcinoma prevention program offered at an inner city church: A pilot project. Cancer. 1999 Dec 15;86(12):2659-67.
46. Zheng W, Lu JJ, Luo F, Zheng Y, Feng Yj, Felix JC, Lauchlan SC, Pike MC. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol. 2000 Jan;76(1):80-8.
47. Paler RJ Jr, Simpson DR, Kaye AM, Gunn S, Felix JC. The relationship of inflammation in the papanicolaou smear to Chlamydia trachomatis infection in a high-risk population. Contraception. 2000 Mar;61(3):231-4.
48. Muderspach L, Wilczynski S, Roman L, Bade L, Felix J, Small LA, Kast WM, Fascio G, Marty V, Weber J. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res. 2000 Sep;6(9):3406-16.
49. Kurman RJ, Félix JC, Archer DF, Nanavati N, Arce J, Moyer DL. Norethindrone acetate and estradiol-induced endometrial hyperplasia. Obstet Gynecol. 2000 Sep;96(3):373-9.
50. Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Gynecol Oncol. 2000 Nov;79(2):169-76.
51. Formenti S, Felix J, Salonga D, Danenberg K, Pike MC, Danenberg P. Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle. Clin Cancer Res. 2000 Dec;6(12):4653-7.
52. Rodgers K, Xiong S, Felix J, Roda N, Espinoza T, Maldonado S, Dizerega G. Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen. 2001;9(3):238-47.
53. Amezcua CA, Bahador A, Naidu YM, Felix JC. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles. Am J Obstet Gynecol. 2001 Jun;184(7):1441-6.
54. Olvera M, Harris S, Amezcua CA, McCourty A, Rezk S, Koo C, Felix JC, Brynes RK. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease. Mod Pathol. 2001 Oct;14(10):1036-42.
55. Moyer DL, Felix JC, Kurman RJ, Cuffie CA. Micronized progesterone regulation of the endometrial glandular cycling pool. Int J Gynecol Pathol. 2001 Oct;20(4):374-9.
56. Cozen W, Peters R, Reichardt JK, Ng W, Felix JC, Wan P, Pike MC. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control. 2002 Mar;13(2):113-20.
57. Goharkhay N, Wing DA, Pan V, McCausland V, Hanna M, Naidu YM, Felix JC. The expression of EP3-6 and inducible nitric oxide synthase messenger RNA are correlated in pregnant and misoprostol-treated but not in nongravid or menopausal myometrium. Am J Obstet Gynecol. 2002 Jun;186(6):1202-6.
58. Felix JC, Lonky NM, Tamura K, Yu KJ, Naidu Y, Lai CR, Lonky SA. Aberrant expression of E-cadherin in cervical intraepithelial neoplasia correlates with a false-negative Papanicolaou smear. Am J Obstet Gynecol. 2002 Jun;186(6):1308-14.
59. Nouriani M, Felix JC, Dubeau L. Histogenesis and histopathological characteristics of Sertoli-Leydig cell tumors CME Journal of Gynecologic Oncology. July 2002;7(2):114-120.
60. Hindle WH, Arias RD, Felix JC, Sueda A. Breast cancer: adaptation of fine-needle aspiration to office practice. Clin Obstet Gynecol. 2002 Sep;45(3):761-6.
61. Hawes D, Liu PY, Muggia FM, Wilczynski S, Cote R, Felix J, Terada K, Belt RJ, Alberts DS. Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study. Gynecol Oncol. 2002 Oct;87(1):17-23.
62. Tourgeman DE, Lu JJ, Boostanfar R, Amezcua C, Felix JC, Paulson RJ. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro. Fertil Steril. 2002 Nov;78(5):1096-9.
63. Monk BJ, Cogan M, Felix JC, Lonky NM, Bentz JS, Marshall CJ, Cestero RM, Rowe LR, Lonky SA. A stiff bristled, spiral-shaped ectocervical brush: a device for transepithelial tissue biopsy. Obstet Gynecol. 2002 Dec;100(6):1276-84.
64. Felix JC, Amezcua C. In vitro adjuncts to the pap smear. Obstet Gynecol Clin North Am. 2002 Dec;29(4):685-99, vii.
65. Boostanfar R, Amezcua CA, Tourgeman DE, Roy S, Felix JC, Stanczyk FZ. Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells. Fertil Steril. 2003 Jan;79(1):223-5.
66. Lonky NM, Felix JC, Naidu YM, Wolde-Tsadik G. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet Gynecol. 2003 Mar;101(3):481-9.
67. Berek JS. Simplification of the new Bethesda 2001 classification system. Am J Obstet Gynecol. 2003 Mar;188(3 Suppl):S2-5; discussion S6-7.
68. Rodgers KE, Espinoza T, Felix J, Roda N, Maldonado S, diZerega G. Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7). Plast Reconstr Surg. 2003 Mar;111(3):1195-206.
69. Felix JC. The science behind the effectiveness of in vivo screening. Am J Obstet Gynecol. 2003 Mar;188(3 Suppl):S8-12.
70. Wing DA, Goharkhay N, Hanna M, Naidu YM, Kovacs BW, Felix JC. EP3-2 receptor mRNA expression is reduced and EP3-6 receptor mRNA expression is increased in gravid human myometrium. J Soc Gynecol Investig. 2003 Apr;10(3):124-9.
71. Pan VL, Goharkhay N, Felix JC, Wing DA. FGL2 prothrombinase messenger RNA expression in gravid and nongravid human myometrium. Am J Obstet Gynecol. 2003 Apr;188(4):1057-62.
72. Wang L, Felix JC, Lee JL, Tan PY, Tourgeman DE, O'Meara AT, Amezcua CA. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus. Gynecol Oncol. 2003 Aug;90(2):402-6.
73. Jain JK, Nicosia AF, Nucatola DL, Lu JJ, Kuo J, Felix JC. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids. 2003 Nov;68(10-13):1115-9.
74. Rodgers KE, Roda N, Felix JC, Espinoza T, Maldonado S, diZerega G: Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice. Exp Dermatol 2003 Dec;12(6):784-90.
75. Padilla-Paz LA, Carlson J, Twiggs LB, Lonky N, Crum CP, Felix J, Hunter V, Krumholz B, Massad LS, Benedet JL: Evidence supporting the current management guidelines for high-grade squamous intraepithelial lesion cytology. J Low Genit Tract Dis. 2004 Apr;8(2):139-46.
76. Lentz SE, Muderspach LI, Felix JC, Ye W, Groshen S, Amezcua CA. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet Gynecol. 2004 Jun;103(6):1204-10.
77. Lonky NM, Felix JC, Tsadik GW, Lonky S: False-negative hybrid capture II results related to altered adhesion molecule distribution in women with atypical squamous cells pap smear results and tissue-based human papillomavirus-positive high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 2004 Oct;8(4):285-91.
78. Amezcua CA, Begley SJ, Mata N, Felix JC, Ballard CA. Aggressive angiomyxoma of the female genital tract: a clinicopathologic and immunohistochemical study of 12 cases. Int J Gynecol Cancer. 2005;15(1):140-5.
79. Eisenkop SM, Spirtos NM, Lin WM, Felix J. Laparoscopic modified radical hysterectomy: a strategy for a clinical dilemma. Gynecol Oncol. 2005 Feb;96(2):484-9.
80. Jain JK, Li A, Minoo P, Nucatola DL, Felix JC. The effect of nonoxynol-9 on human endometrium. Contraception. 2005 Feb;71(2):137-42.
81. Li A, Felix JC, Hao J, Minoo P, Jain JK. Menstrual-like breakdown and apoptosis in human endometrial explants. Hum Reprod. 2005 Jun;20(6):1709-19.
82. Li A, Felix JC, Minoo P, Amezcua CA, Jain JK. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. Fertil Steril. 2005 Jul;84(1):202-11.
83. Jain JK, Li A, Nucatola DL, Minoo P, Felix JC. Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways. Biol Reprod. 2005 Aug;73(2):382-8.
84. Cremer M, Jamshidi RM, Muderspach L, Tsao-Wei D, Felix JC, Blumenthal PD. Digital camera assessment for detection of cervical intraepithelial neoplasia in rural El Salvador. Int J Gynaecol Obstet. 2005 Oct;91(1):42-6.
85. Kobak W, Lu J, Hardart A, Zhang C, Stanczyk FZ, Felix JC. Expression of lysyl oxidase and transforming growth factor beta2 in women with severe pelvic organ prolapse. J Reprod Med. 2005 Nov;50(11):827-31.
86. Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman LD. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 2006 Feb;100(2):288-93.
87. Jain JK, Li A, Yang W, Minoo P, Felix JC. Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate. Hum Reprod. 2006 Mar;21(3):798-809.
88. Wing DA, Goharkhay N, Felix JC, Rostamkhani M, Naidu YM, Kovacs BW. Expression of the oxytocin and V1a vasopressin receptors in human myometrium in differing physiologic states and following misoprostol administration. Gynecol Obstet Invest. 2006;62(4):181-5.
89. Amezcua CA, MacDonald HR, Lum CA, Yi W, Muderspach LI, Roman LD, Felix JC. Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes. Int J Gynecol Cancer. 2006;16(3):1336-41.
90. Jain JK, Li A, Yang W, Minoo P, Felix JC. Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate. Fertil Steril. 2007 Jan;87(1):8-23.
91. Steiner AZ, Xiang M, Mack WJ, Shoupe D, Felix JC, Lobo RA, Hodis HN. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials. Obstet Gynecol. 2007 Mar;109(3):581-7.
92. White T, Felix JC. Pelvic actinomycosis with retained intrauterine fetal bone: a case report. J Reprod Med. 2007 Mar;52(3):220-2.
93. Minaglia S, Terbell H, Felix JC, Ballard CA. Polypoid cystitis resulting from ovarian abscess. Int Urogynecol J Pelvic Floor Dysfunct. 2007 May;18(5):579-82.
94. Li A, Felix JC, Yang W, Xiong DW, Minoo P, Jain JK. Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users. Contraception. 2007 Jul;76(1):57-65.
95. Roman LD, Wilczynski S, Muderspach LI, Burnett AF, O'Meara A, Brinkman JA, Kast WM, Facio G, Felix JC, Aldana M, Weber JS. A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Gynecol Oncol. 2007 Sep;106(3):558-66.
96. Goharkhay N, Lu J, Felix JC, Wing DA. Expression of calcitonin gene-related peptide-receptor component protein (CGRP-RCP) in human myometrium in differing physiological states and following misoprostol administration. Am J Perinatol. 2007 Sep;24(8):497-500.
97. Archer DF, Hendrix S, Ferenczy A, Felix JC, Gallagher JC, Rymer J, Skouby SO, den Hollander W, Stathopoulos V, Helmond FA: THEBES Study Group. Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women. Fertil Steril 2007 Oct;88(4):866-78.
98. Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR Jr. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Menopause. 2008;15(1):94-7.
99. Li A, Felix JC, Yang W, Jain JK. Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users. Fertil Steril. 2008 Sep;90(3):872-5.
100. Klutke J, Ji Q, Campeau J, Starcher B, Felix JC, Stanczyk FZ, Klutke C. Decreased endopelvic fascia elastin content in uterine prolapse. Acta Obstet Gynecol Scand. 2008;87(1):111-5.
101. Davis-Dao CA, Cremer M, Felix J, Cortessis VK: Effect of cervicitis on visual inspection with acetic acid. J Low Genit Tract Dis 2008 Oct;12(4):282-6.
102. Lee RH, Goodwin TM, Yang W, Li A, Wilson ML, Mullin PM, Felix JC. Quantitative detection of EP3-II, III and VI messenger RNA in gravid and non-gravid human myometrium using real-time RT-PCR. J Matern Fetal Neonatal Med. 2009 Jan;22(1):59-64.
103. Li A, Lee RH, Felix JC, Minoo P, Goodwin TM. Alteration of secretory leukocyte protease inhibitor in human myometrium during labor. Am J Obstet Gynecol. 2009 Mar;200(3):311.e1-311.e10.
104. Felix JC, Burks RT, Amezcua CA. Vulva and vagina Modern Surgical Pathology. 29 June 2009:1237-1262.
105. Cremer ML, Conlisk E, Felix JC. HPV screening for cervical cancer in rural India. N Engl J Med. 2009 Jul 16;361(3):305; author reply 306.
106. Cremer ML, Peralta EI, Dheming SG, Jimenez ME, Davis-Dao CA, Alonzo TA, Blumenthal PD, Felix JC. Digital assessment of the reproductive tract versus colposcopy for directing biopsies in women with abnormal Pap smears. J Low Genit Tract Dis. 2010 Jan;14(1):5-10.
107. Cremer ML, Alonzo TA, Alspach AE, Shulman IA, Cernosek S, Tsai S, Kalichanda N, Felix JC. Diagnostic reproducibility of cervical intraepithelial neoplasia 3 and atrophy in menopausal women on hematoxylin and eosin, Ki-67, and p16 stained slides. J Low Genit Tract Dis. 2010 Apr;14(2):108-12.
108. Lonky NM, Mahdavi A, Wolde-Tsadik G, Bajamundi K, Felix JC. Evaluation of the clinical performance of high-risk human papillomavirus testing for primary screening: a retrospective review of the Southern California Permanente Medical Group experience. J Low Genit Tract Dis. 2010 Jul;14(3):200-5.
109. Patel S, Li A, Goodwin TM, Brower M, Blitz M, Minoo P, Felix JC, Lee RH. Effect of 17-alpha hydroxyprogesterone caproate on the production of tumor necrosis factor-alpha and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants. J Perinatol. 2010 Sep;30(9):584-9.
110. Noé G, Sitruk-Ware R, Zegers-Hochschild F, Variano B, Montero JC, Arriagada P, Li A, Stanczyk FZ, Felix JC, Mishell DR, Croxatto HB. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women. Climacteric. 2010 Oct;13(5):433-41.
111. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010 Nov;116(5):1150-7.
112. Lewis RA, Taylor D, Natavio MF, Melamed A, Felix J, Mishell D Jr. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability. Contraception. 2010 Dec;82(6):491-6.
113. Cremer M, Bullard K, Maza M, Peralta E, Moore E, Garcia L, Masch R, Lerner V, Alonzo TA, Felix J. Cytology versus visual inspection with acetic acid among women treated previously with cryotherapy in a low-resource setting. Int J Gynaecol Obstet. 2010 Dec;111(3):249-52.
114. Cremer M, Conlisk E, Maza M, Bullard K, Peralta E, Siedhoff M, Alonzo T, Felix J. Adequacy of visual inspection with acetic acid in women of advancing age. Int J Gynaecol Obstet. 2011 Apr;113(1):68-71.
115. Nelken RS, Ozel BZ, Leegant AR, Felix JC, Mishell DR Jr. Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder. Menopause. 2011 Sep;18(9):962-6.
116. Winter M, Cestero RM, Burg A, Felix JC, Han C, Raffo AM, Vasilev S. Fabric-based exocervical and endocervical biopsy in comparison with punch biopsy and sharp curettage. J Low Genit Tract Dis. 2012 Apr;16(2):80-7.
117. Srivastava SA, Wang Y, Vallone J, Felix JC. Primary clear cell carcinoid tumors of the vulva. Am J Surg Pathol. 2012 Sep;36(9):1371-5.
118. Natavio MF, Taylor D, Lewis RA, Blumenthal P, Felix JC, Melamed A, Gentzschein E, Stanczyk FZ, Mishell DR Jr. Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine system. Contraception. 2013 Apr;87(4):426-31.
119. Quaas AM, Kono N, Mack WJ, Hodis HN, Felix JC, Paulson RJ, Shoupe D. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial. Menopause. 2013 Aug;20(8):840-4. PMCID: PMC3934100
120. Li A, Chan B, Felix JC, Xing Y, Li M, Brody SL, Borok Z, Li C, Minoo P. Tissue-dependent consequences of Apc inactivation on proliferation and differentiation of ciliated cell progenitors via Wnt and notch signaling. PLoS One. 2013;8(4):e62215. PMCID: PMC3639955
121. Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L. Endometrial echo complex thickness in postmenopausal endometrial cancer. Gynecol Oncol. 2013 Oct;131(1):109-12.
122. Diedrich JT, Felix JC, Lonky NM: Contribution of exocervical biopsy, endocervical curettage, and colposcopic grading in diagnosing high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2014 Jan 28.
123. Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol. 2014 Apr;210(4):366.e1-366.e5.
124. Guo J, Cremer M, Maza M, Alfaro K, Felix JC. Evaluation of a low-cost liquid-based Pap test in rural El Salvador: a split-sample study. J Low Genit Tract Dis. 2014 Apr;18(2):151-5.
125. Blue NR, Felix JC, Jaque J. Primary ovarian leiomyoma in a premenarchal adolescent: first reported case. J Pediatr Adolesc Gynecol. 2014 Aug;27(4):e87-8.
126. Patel S, Pinheiro M, Felix JC, Opper N, Ouzounian JG, Lee RH. A case-control review of placentas from patients with intrahepatic cholestasis of pregnancy. Fetal Pediatr Pathol. 2014 Aug;33(4):210-5.
127. Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, Felix JC, Castle PE, Villalta S, Miranda E, Cremer ML. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynaecol Obstet. 2014 Aug;126(2):156-60.
128. Diedrich JT, Felix JC, Lonky NM: Do colposcopically directed biopsy and endocervical curettage serve to induce regression of cervical intraepithelial neoplasia? J Low Genit Tract Dis. 2014 Oct;18(4):322-5.
129. Medeiros F, Felix JC. Intraoperative frozen section consultation in gynecologic pathology. Methods Mol Biol. 2014;1180:209-20.
130. Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. Int J Cancer. 2015 Aug 15;137(4):893-902.
131. Stany MP, Stone PJ, Felix JC, Amezcua CA, Groshen S, Ye W, Kyser KL, Howard RS, Zahn CM, Muderspach LI, Lentz SE, Chernofsky MR. Lymph Node Micrometastases in Early-Stage Cervical Cancer are Not Predictive of Survival. Int J Gynecol Pathol. 2015 Jul;34(4):379-84. PMCID: PMC7710669
132. Alfaro KM, Gage JC, Rosenbaum AJ, Ditzian LR, Maza M, Scarinci IC, Miranda E, Villalta S, Felix JC, Castle PE, Cremer ML. Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program. BMC Public Health. 2015 Oct 16;15:1058. PMCID: PMC4609068
133. Brueggmann D, Opper N, Felix J, Groneberg DA, Mishell DR Jr, Jaque JM: Development of a cost-effective educational tool to promote acceptance of the HPV vaccination by hispanic mothers. J Community Health. 2015 Oct 29. [Epub ahead of print] PMID: 26516016.
134. Felix JC, Lacey MJ, Miller JD, Lenhart GM, Kulkarni R. Clinical-Economic Modeling Analysis Of Human Papillomavirus (Hpv) Co-Testing With Genotyping Versus Primary Hpv Testing For Cervical Cancer Screening. Value Health. 2015 Nov;18(7):A353.
135. Diedrich JT, Felix JC, Lonky NM. Contribution of Exocervical Biopsy, Endocervical Curettage, and Colposcopic Grading in Diagnosing High-Grade Cervical Intraepithelial Neoplasia. J Low Genit Tract Dis. 2016 Jan;20(1):52-6.
136. Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. N Engl J Med. 2016 Mar 31;374(13):1221-31. PMCID: PMC4921205
137. Felix J. mRNA-based hrHPV assay in cotesting for cervical cancer screening. MLO Med Lab Obs. 2016 Apr;48(4):22-3.
138. Cremer ML, Maza M, Alfaro KM, Kim JJ, Ditzian LR, Villalta S, Alonzo TA, Felix JC, Castle PE, Gage JC. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador. J Low Genit Tract Dis. 2016 Apr;20(2):145-50. PMCID: PMC4819528
139. Brueggmann D, Opper N, Felix J, Groneberg DA, Mishell DR Jr, Jaque JM. Development of a Cost-Effective Educational Tool to Promote Acceptance of the HPV Vaccination by Hispanic Mothers. J Community Health. 2016 Jun;41(3):468-75.
140. Felix JC, Lacey MJ, Miller JD, Lenhart GM, Spitzer M, Kulkarni R. The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis. J Womens Health (Larchmt). 2016 Jun;25(6):606-16. PMCID: PMC4900245
141. Cremer M, Garai J, Taxa L, Salinas M, Felix J, Alfaro K, Haas M, Zevallos A. CryoPen®, A gasless cryotherapy system adapted for low-resource settings 2016 IEEE Healthcare Innovation Point-of-Care Technologies Conference, HI-POCT 2016. 27 December 2016:130-133.
142. Felix JC. Primary HPV testing vs. Co-testing for cervical cancer screening: Outcome and economic support that co-testing is superior Contemporary Ob/Gyn. 2016;61(9):2-5.
143. Cremer M, Maza M, Alfaro K, Morales Velado M, Felix J, Castle PE, Kim J, Gage JC. Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador. J Low Genit Tract Dis. 2017 Jan;21(1):26-32. PMCID: PMC5201413
144. Maza M, Alfaro K, Garai J, Velado MM, Gage JC, Castle PE, Felix J, Luciani S, Campos N, Kim J, Masch R, Cremer M. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country. Gynecol Oncol Rep. 2017 May;20:58-61. PMCID: PMC5352717
145. H Chon A, Takeda MR, Felix JC, Chmait RH. A Complication of Percutaneous Sclerotherapy for Congenital Pulmonary Airway Malformation: Intravascular Injection and Cardiac Necrosis. Fetal Pediatr Pathol. 2017 Dec;36(6):437-444.
146. Taxa L, Jeronimo J, Alonzo TA, Gage J, Castle PE, Cremer ML, Felix JC: Depth of Cervical Intraepithelial Neoplasia Grade 3 in Peruvian Women: Implications for Therapeutic Depth of Necrosis. J Low Genit Tract Dis. 2018 Jan; 22(1):27-30.
147. Maza M, Figueroa R, Laskow B, Juárez A, Alfaro K, Alonzo TA, Felix JC, Gage JC, Cremer M. Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions. J Low Genit Tract Dis. 2018 Jan;22(1):47-51.
148. Maza M, Melendez M, Masch R, Alfaro K, Chacon A, Gonzalez E, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M. Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador. Prev Med. 2018 Sep;114:149-155.
149. Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador. Int J Gynaecol Obstet. 2019 Apr;145(1):40-46. PMCID: PMC6988124
150. Cremer M, Alfaro K, Garai J, Salinas M, Maza M, Zevallos A, Taxa L, Diaz AC, Castle P, Alonzo TA, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Felix JC. Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: a randomized non-inferiority study. Int J Gynecol Cancer. 2019 May 03. PMCID: PMC9884482
151. Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim JJ. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Prev Med. 2020 Feb;131:105931.
152. Kravtsov O, Hartley CP, Sheinin Y, Hunt BC, Felix JC, Giorgadze T. Utility of PD-L1 testing on non-small cell lung cancer cytology specimens: An institutional experience with interobserver variability analysis. Ann Diagn Pathol. 2020 Oct;48:151602.
153. Alfaro K, Maza M, Felix JC, Gage JC, Castle PE, Alonzo TA, Chacón A, González E, Soler M, Conzuelo-Rodriguez G, Masch R, Cremer M. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador. JCO Glob Oncol. 2020 Oct;6:1519-1530. PMCID: PMC7605377
154. Goldstein A, Lei Y, Goldstein L, Goldstein A, Bai QX, Felix J, Lipson R, Demarco M, Schiffman M, Egemen D, Desai KT, Bedell S, Gersten J, Goldstein G, O’Keefe K, O’Keefe C, O’Keefe T, Sebag C, Lobel L, Zhao A, Lu YL. A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing Infectious Agents and Cancer. 1 December 2020;15(1).
155. Luo L, Chen Y, Chen X, Zheng Y, Zhou V, Yu M, Burns R, Zhu W, Fu G, Felix JC, Hartley C, Damnernsawad A, Zhang J, Wen R, Drobyski WR, Gao C, Wang D. Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity. J Immunol. 2020 Dec 15;205(12):3480-3490. PMCID: PMC7955895
156. Parra SG, López-Orellana LM, Molina Duque AR, Carns JL, Schwarz RA, Smith CA, Ortiz Silvestre M, Diaz Bazan S, Escobar PA, Felix JC, Ramalingam P, Castle PE, Cremer ML, Maza M, Schmeler KM, Richards-Kortum RR. Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer. Int J Cancer. 2020 Dec 24.
157. Hooper JE, Padera RF, Dolhnikoff M, da Silva LFF, Duarte-Neto AN, Kapp ME, Lacy JM, Mauad T, Saldiva PHN, Rapkiewicz AV, Wolf DA, Felix JC, Benson P, Shanes E, Gawelek KL, Marshall DA, McDonald MM, Muller W, Priemer DS, Solomon IH, Zak T, Bhattacharjee MB, Fu L, Gilbert AR, Harper HL, Litovsky S, Lomasney J, Mount SL, Reilly S, Sekulic M, Steffensen TS, Threlkeld KJ, Zhao B, Williamson AK. A Postmortem Portrait of the Coronavirus Disease 2019 (COVID-19) Pandemic: A Large Multi-institutional Autopsy Survey Study. Arch Pathol Lab Med. 2021 May 01;145(5):529-535.
158. Puzyrenko A, Felix JC, Sun Y, Rui H, Sheinin Y. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature. Pathol Res Pract. 2021 Apr;220:153380. PMCID: PMC7883708
159. Parra SG, López-Orellana LM, Molina Duque AR, Carns JL, Schwarz RA, Smith CA, Ortiz Silvestre M, Diaz Bazan S, Felix JC, Ramalingam P, Castle PE, Cremer ML, Maza M, Schmeler KM, Richards-Kortum RR. Reply to: Comments on Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer. Int J Cancer. 2021 Apr 04.
160. Felix JC, Sheinin YM, Suster D, Ronen N, Ratiani M, Vanden Heuvel T, Winge E, Patton MD, Rau MJ, Ge L, Sun Y, Udhane SS, Langenheim JF, Rui H. Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness. Ann Diagn Pathol. 2021 Aug;53:151744. PMCID: PMC8053602
161. Desai KT, Alfaro K, Mendoza L, Faron M, Mesich B, Maza M, Dominguez R, Valenzuela A, Acosta CD, Martínez M, Felix JC, Masch R, Gabrilovich S, Plump M, Novetsky AP, Einstein MH, Douglas NC, Cremer M, Wentzensen N. Multi-site clinical validation of Isothermal Amplification based SARS-COV-2 detection assays using different sampling strategies. medRxiv. 2021 Jul 06. PMCID: PMC8282105
162. Puzyrenko A, Jacobs ER, Sun Y, Felix JC, Sheinin Y, Ge L, Lai S, Dai Q, Gantner BN, Nanchal R, North PE, Simpson PM, Rui H, Benjamin IJ. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies. Cell Stress Chaperones. 2021 Sep;26(5):859-868. PMCID: PMC8357488
163. Sun Y, Ge L, Udhane SS, Langenheim JF, Rau MJ, Patton MD, Gallan AJ, Felix JC, Rui H. Sensitive and Specific Immunohistochemistry Protocol for Nucleocapsid Protein from All Common SARS-CoV-2 Virus Strains in Formalin-Fixed, Paraffin Embedded Tissues. Methods Protoc. 2021 Jul 10;4(3). PMCID: PMC8293419
164. Lonky NM, Xu L, Da Silva DM, Felix JC, Chao C. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California. Am J Obstet Gynecol. 2021 Dec;225(6):656.e1-656.e11.
165. Desai KT, Alfaro K, Mendoza L, Faron M, Mesich B, Maza M, Dominguez R, Valenzuela A, Acosta CD, Martínez M, Felix JC, Masch R, Smith JS, Gabrilovich S, Wu T, Plump M, Novetsky AP, Einstein MH, Douglas NC, Cremer M, Wentzensen N. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies. Microbiol Spectr. 2021 Oct 31;9(2):e0084621. PMCID: PMC8528118
166. Puzyrenko A, Felix JC, Ledeboer NA, Sun Y, Rui H, Sheinin Y. Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis. Pathology. 2022 Jun;54(4):404-408. PMCID: PMC8572726
167. Alfaro K, Soler M, Maza M, Flores M, López L, Rauda JC, Chacón A, Erazo P, Villatoro N, Mumenthaler E, Masch R, Conzuelo G, Felix JC, Cremer M. Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future. Cancers (Basel). 2022 Jun 03;14(11). PMCID: PMC9179345
 
Books, Chapters, and Reviews
1. Neutrophil Function in Burn Patients: Felix JC and Davis JM. In: Advances in Host Defense Mechanisms. Ed. JI Gallin, A.S. Fauci, Vol 6 Host Defenses in Trauma and Surgery, Guest Ed. JM Davis, GT Shires, Raven Press, New York, 1986.
2. Gynecologic and Testicular Neoplasms: Felix JC, Sherrod AE and Taylor CR: In: Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist, Ed. Taylor CR and Cote RC, Second Edition, W.B. Saunders Co., 1994.
3. Fine-needle aspiration cytology of the breast: Florentine B and Felix JC. In: Breast care, Ed. Hindle WH, Springer-Verlag, New York, 1998.
4. Pathology of the female breast: Felix JC. In: Breast care, Ed. Hindle WH, Springer- Verlag, New York, 1998.
5. Therapeutics-cancer of the endometrium, ovary, and cervix: Felix JC, Kurman RJ. In: Estrogens and progestogens in Clinical Practice, Eds. Fraser IS, Jansen R, Lobo RA, Whitehead M, First Edition, Churchill Livingstone, London, 1998.
6. The Papanicolaou Smear: Liquid-Based, Thin-Layer Cytology: Felix JC. In: Colposcopy Principles and Practice: An Integrated Textbook and Atlas, Eds. Apgar BS, Brotzman GL, Spitzer M, W.B. Saunders Co. New York, 2002.
7. Vulva and Vagina: Burks RT, Felix JC, In: Modern Surgical Pathology, Female Reproductive System. Weidner N, Cote RC, Suster S, Weiss LM. Saunders Co. PA, 2003.
8. Cervix: Wright TC, Felix JC, In: Modern Surgical Pathology, Female Reproductive System. Weidner N, Cote RC, Suster S, Weiss LM Saunders Co. PA, 2003.
9. Felix JC, Wright TC, Amezcua CA. Cervix Modern Surgical Pathology. 2009;2:1263-1294.
10. Felix JC, Burks RT, Amezcua CA. Vulva and Vagina Modern Surgical Pathology. 2009;2:1237-1262.
 
Non-Refereed Journal Publications/Original Papers
1. Wright TC, Felix JC. Problem is recurrent benign endocervical polyps Contemporary Ob-Gyn. 1997;42(5):146-158.
2. Wright TC, Felix JC. Symptoms are bilateral adnexal masses Contemporary Ob-Gyn. 1996;41(9):61-69.
3. Wright TC, Felix JC. Symptoms are spotting and a solid adnexal mass Contemporary Ob-Gyn. 1996;41(10):61-66.
4. Wright TC, Felix JC. Symptoms are uterine bleeding and ovarian mass Contemporary Ob-Gyn. 1996;41(8):59-64.